Literature DB >> 7900941

Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease.

G M Schuermann1, A E Aber-Bishop, P Facer, J C Lee, D S Rampton, C J Doré, J M Polak.   

Abstract

Adhesion of circulating cells to vascular endothelium occurs in the early phase of inflammation, and is mediated by specific cell adhesion molecules. Many such adhesion molecules are increased in inflamed regions of ulcerative colitis (UC) and Crohn's disease (CD) but there is limited knowledge of their expression in the uninvolved gut, adjacent to inflammation. We investigated immunohistochemically the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1) on resected specimens taken at a distance of 2-4 cm from the inflamed area and without histological signs of inflammation. Compared with normal gut, we found (i) a significant increase of PECAM-1-positive vessels in the mucosa of uninvolved UC (149.0 +/- 24.1 vessels/mm2 (mean +/- s.d.); normal colon = 123.1 +/- 21.6; P = 0.004); (ii) a significant decrease of ICAM-1-positive vessels in uninvolved CD (111.9 +/- 22.6 vessels/mm2; normal ileum = 136.9 +/- 27.6; P = 0.04); and (iii) a moderate but statistically insignificant increase of LFA-1-positive cells in the mucosa of uninvolved UC and Crohn's ileitis. This altered expression of cell adhesion molecules may contribute to the early lesion in inflammatory bowel disease and provide new therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7900941      PMCID: PMC1534226          DOI: 10.1111/j.1365-2249.1993.tb03455.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.

Authors:  K Koretz; F Momburg; H F Otto; P Möller
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

2.  Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.

Authors:  C O'Morain; A E Bishop; G P McGregor; A J Levi; S R Bloom; J M Polak; T J Peters
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

3.  T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1.

Authors:  M L Dustin; T A Springer
Journal:  Nature       Date:  1989-10-19       Impact factor: 49.962

4.  Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

Authors:  C W Smith; S D Marlin; R Rothlein; C Toman; D C Anderson
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Thromboembolism in inflammatory bowel disease: role of platelets.

Authors:  M J Webberley; M T Hart; V Melikian
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

6.  Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies.

Authors:  R Rothlein; M Czajkowski; M M O'Neill; S D Marlin; E Mainolfi; V J Merluzzi
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

7.  A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits.

Authors:  N B Vedder; R K Winn; C L Rice; E Y Chi; K E Arfors; J M Harlan
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

8.  Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.

Authors:  S H Saverymuttu; M Camilleri; H Rees; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

9.  Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.

Authors:  A E Bishop; J M Polak; M G Bryant; S R Bloom; S Hamilton
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

10.  Differentiation between Crohn's disease and other inflammatory conditions by electron microscopy.

Authors:  A M Dvorak; W Silen
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

View more
  15 in total

1.  Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease.

Authors:  B Vainer; O H Nielsen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Adhesion molecules in chronic ulcerative colitis.

Authors:  Maya V Gulubova; Irena M Manolova; Tatyana I Vlaykova; Margarita Prodanova; Jovcho P Jovchev
Journal:  Int J Colorectal Dis       Date:  2006-11-16       Impact factor: 2.571

3.  Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease.

Authors:  Phillip Gu; Arianne Theiss; Jie Han; Linda A Feagins
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

4.  Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts.

Authors:  M Bajaj-Elliott; E Breese; R Poulsom; P D Fairclough; T T MacDonald
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

5.  ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease.

Authors:  E Rijcken; C F Krieglstein; C Anthoni; M G Laukoetter; R Mennigen; H U Spiegel; N Senninger; C F Bennett; G Schuermann
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease.

Authors:  Silvana Geleff; Sebastian F Schoppmann; Georg Oberhuber
Journal:  Virchows Arch       Date:  2003-01-16       Impact factor: 4.064

7.  Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

Authors:  F Magro; F Araujo; P Pereira; E Meireles; M Diniz-Ribeiro; F Tavarela Velosom
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

8.  Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models.

Authors:  Ben Vainer; Susanne Sørensen; Jakob Seidelin; Ole Haagen Nielsen; Thomas Horn
Journal:  Virchows Arch       Date:  2003-10-16       Impact factor: 4.064

9.  Small bowel transplantation in children: an immunohistochemical study of intestinal grafts.

Authors:  G Fromont; N Cerf-Bensussan; N Patey; D Canioni; C Rambaud; O Goulet; D Jan; Y Révillon; C Ricour; N Brousse
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

10.  Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease.

Authors:  G M Schürmann; A E Bishop; P Facer; M Vecchio; J C Lee; D S Rampton; J M Polak
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.